GPT and metabolic dysfunction-associated steatotic liver disease: Moreover, 20% of patients had liver disease, including nonalcoholic fatty liver disease or elevated alanine aminotransferase levels; Olfactory impairment was relatively rare (10.5%), and no hearing impairment was observed in our cohort.